Solta's LIPOSONIX Reaches the U.S. - Analyst Blog
13 Enero 2012 - 6:00AM
Zacks
Aesthetic laser treatments provider
Solta Medical (SLTM) reported the arrival of its
ground-breaking LIPOSONIX system in the U.S. The California-based
company stated that the device is now also available in Canada.
LIPOSONIX uses advanced non-invasive ultrasound energy to reduce
abdominal fat.
Solta Medical obtained the rights
to the LIPOSONIX system through its takeover of Medicis
Technologies Corporation, a unit of specialty pharmaceutical
company Medicis Pharmaceutical Corporation (MRX),
under a deal worth roughly $35 million. The acquisition, which was
closed in November 2011, provided the company a complementary
technology and enabled it to foray into the lucrative and growing
non-invasive fat reduction market.
LIPOSONIX is not a replacement for
liposuction surgery but offers a non-surgical approach to reduce
waist circumference when diet and exercise are not enough. It is an
effective treatment with a proven safety profile.
Unlike other non-invasive fat
reduction therapies, LIPOSONIX permanently ablates the fat cells
found under the skin with just a single treatment procedure that
takes about an hour. Studies have shown an average waist
circumference reduction of roughly 2.6 cm (1 nch) following one
LIPOSONIX treatment.
Solta Medical develops and markets
devices for aesthetic applications and is a global leader in the
medical aesthetics market. The company derives its revenues
primarily from the sale of its systems, treatment tips and other
consumables. Solta competes with Allergan Inc.
(AGN), Syneron Medical (ELOS),
Cutera (CUTR) and Palomar Medical
Technologies (PMTI).
Over a half million fat reduction
treatments were performed in the U.S. last year. The
non-invasive fat reduction market is forecast to grow by 42%
annually through 2016, providing a compelling opportunity for Solta
Medical.
ALLERGAN INC (AGN): Free Stock Analysis Report
CUTERA INC (CUTR): Free Stock Analysis Report
SYNERON MED LTD (ELOS): Free Stock Analysis Report
MEDICIS PHARM-A (MRX): Free Stock Analysis Report
PALOMAR MED TEC (PMTI): Free Stock Analysis Report
SOLTA MEDICAL (SLTM): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024